cardiovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged > 18 and = 80 year; 2. Patients with stable angina, unstable angina or non-ST elevation myocardial infarction; 3. Patients with de novo coronary bifurcation lesions (Medina 0,1,11,1,11,0,1) and the diameter of the main branch = 2.5 mm and the side-branch = 2.25 mm by visually angiographic estimation 4. Lesions suitable to PCI (for instance, left main bifurcated lesion with SYNTAX score = 32), and suitable to 2-stent implantation as necessary; 5. Patients willing to participating and following up; 6. Patients (or legal guardian) understanding the trial protocol and requirement with written consent.
Exclusion criteria
Exclusion criteria: 1. Lesions unsuitable to 2-stent implantation (for instances, chronic total occlusion with either of branches unable to recanalization, severely calcified bifurcation lesion requiring rotablation, or the side-branch 700 × 10^9/L, white count5 URL)or renal dysfunction (eGRF<30ml/min/1.73m2), congestive heart failure (NYHA= III) etc. 6. Severe illness with life expectance of less 12 months, for instances, cancers, other end-stage deceases; 7. Women with or planning to pregnancy; 8. Patients with contraindications or allergies to the stent platforms or the associated medications, for instances, stent eluting drugs, stainless steel or alloy, aspirin, P2Y12 inhibitors, contrast agents, etc.; 9. Patients participating another drug or instrument ongoing trial, or planning to participate another drug or instrument trial within 12 month post-procedurally.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The rate of the target lesion failure (TLF); | — |
Countries
China
Contacts
Fujian Medical University, Union Hospital